Skip to main content
Premium Trial:

Request an Annual Quote

Lasker for mRNA Vaccine Work

Researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners, The Scientist reports.

BioNTech's Katalin Karikó and Drew Weissman from the University of Pennsylvania are the recipients of the 2021 Lasker~DeBakey Clinical Medical Research Award for their work modifying messenger RNA so that cells would take it up and use it to produce proteins, rather than destroy it, The Scientist adds. This, the Lasker Foundation notes, enabled the development of mRNA-based vaccines, such as ones now deployed against COVID-19.

"So many enigmatic things about RNA I find very, very exciting," Karikó says in a press release from Penn Medicine, where she is also an adjunct professor. "And I am so glad that it eventually helped humanity." 

Other Lasker winners include Stanford University's Karl Deisseroth, Humboldt University of Berlin's Peter Hegemann, and the Max Planck Institute of Biochemistry's Dieter Oesterhelt for their work on optogenetics, and the California Institute of Technology's David Baltimore won for his leadership and science advocacy.

Earlier this month, Karikó and Weissman won the 2021 Breakthrough Prize in Life Sciences.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.